Amount of interleukin-1β and interleukin-1 receptor antagonist in periodontitis and healthy patients

被引:32
|
作者
Gilowski, Lukasz [1 ]
Wiench, Rafal [2 ]
Plocica, Iwona [2 ]
Krzeminski, Tadeusz Faustyn [1 ]
机构
[1] Med Univ Silesia, Sch Med, Div Dent, Chair & Dept Pharmacol, PL-41808 Zabrze, Poland
[2] Med Univ Silesia, Sch Med, Div Dent, Chair & Dept Conservat Dent Endodont, PL-41808 Zabrze, Poland
关键词
Interleukin-1; beta; Interleukin-1 receptor antagonist; Chronic periodontitis; Gingival crevicular fluid; GINGIVAL CREVICULAR FLUID; BONE-RESORBING ACTIVITY; RHEUMATOID-ARTHRITIS; INFLAMMATION; METAANALYSIS; EXPRESSION; IL-1-BETA; DISEASE; STRESS;
D O I
10.1016/j.archoralbio.2014.04.007
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective: Regulation of interleukin-1 beta (IL-1 beta) is a critical element of immune responses in health and disease. Additional research is required to determine the levels of interleukin-1 receptor antagonist (IL:1ra) sufficient to inhibit inteleukine-1-induced responses in periodontium. The aim of this study was to compare the levels of IL-1 beta, IL-1ra in gingival crevicular fluid samples obtained from periodontitis and healthy patients. Design of the study: The periodontitis group consisted of 50 patients (F-31, M-19) with chronic periodontitis. The control group consisted of 30 periodontally healthy subjects (F-19, M-11). Oral hygiene index-simplified, gingival index, pocket depth, clinical attachment level were measured. The concentrations of interleukins in gingival crevicular fluid were measured by the ELISA technique. Results: The total amounts of interleukin-1 beta and IL-1ra were significantly higher in periodontitis group than in the control group (P < 0.05). The levels of each cytokine were reported also as moles. In the control group there were 800-times more moles/sample of IL-1ra than IL-1 beta. In periodontitis group nearly 300-times more moles/sample of IL-1ra was obtained. The significant positive Spearman's rank correlations was identified between both concentrations (R = 0.39; P < 0.05) and total amounts (R = 0.31; P < 0.05) of cytokines in the periodontitis group. Conclusion: The increased secretion of IL-1ra in periodontitis is not adequate to "curb" the release of IL-1 beta. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:729 / 734
页数:6
相关论文
共 50 条
  • [41] Genetic variation of the interleukin-1 family and nongenetic factors determining the interleukin-1 receptor antagonist phenotypes
    Luotola, Kari
    Pietila, Arto
    Alanne, Mervi
    Lanki, Timo
    Loo, Britt-Marie
    Jula, Antti
    Perola, Markus
    Peters, Annette
    Zeller, Tanja
    Blankenberg, Stefan
    Salomaa, Veikko
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2010, 59 (10): : 1520 - 1527
  • [42] Interleukin-6, interleukin-1 beta and interleukin-1 receptor antagonist levels in epileptic seizures
    Uludag, Irem Fatma
    Bilgin, Sule
    Zorlu, Yasar
    Tuna, Gamze
    Kirkali, Guldal
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2013, 22 (06): : 457 - 461
  • [43] Evaluation of interleukin-1 beta and the ratio of interleukin-1 beta to interleukin-1 receptor antagonist in gingival crevicular fluid during orthodontic canine retraction
    Motyl, Sylwia
    Manfredini, Daniele
    Oruba, Zuzanna
    Bugajska, Jolanta
    Sztefko, Krystyna
    Stos, Wojciech
    Osiewicz, Magdalena
    Loster, Bartlomiej Wincenty
    Lobbezoo, Frank
    DENTAL AND MEDICAL PROBLEMS, 2021, 58 (01) : 47 - 54
  • [44] Serum interleukin-1β in subjects with abdominal obesity and periodontitis
    Satpathy, Anurag
    Ravindra, Shivamurthy
    Thakur, Srinath
    Kulkarni, Sudhindra
    Porwal, Amit
    Panda, Saurav
    OBESITY RESEARCH & CLINICAL PRACTICE, 2015, 9 (05) : 513 - 521
  • [45] Haplotypes of the interleukin-1 receptor antagonist gene, interleukin-1 receptor antagonist mRNA levels and the risk of myocardial infarction
    van Minkelen, Rick
    Wettinger, Stephanie Bezzina
    de Visser, Marieke C. H.
    Vos, Hans L.
    Reitsma, Pieter H.
    Rosendaal, Frits R.
    Bertina, Rogier M.
    Doggen, Carine J. M.
    ATHEROSCLEROSIS, 2009, 203 (01) : 201 - 205
  • [46] Placental Secretion of Interleukin-1 and Interleukin-1 Receptor Antagonist in Preeclampsia: Effect of Magnesium Sulfate
    Amash, Alaa
    Holcberg, Gershon
    Sapir, Olga
    Huleihel, Mahmoud
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2012, 32 (09): : 432 - 441
  • [47] The roles of interleukin-1 and interleukin-1 receptor antagonist in antigen-specific immune responses
    Lin, KW
    Chen, SC
    Chang, FH
    Kung, JT
    Hsu, BRS
    Lin, RH
    JOURNAL OF BIOMEDICAL SCIENCE, 2002, 9 (01) : 26 - 33
  • [48] Effect of interleukin-1 on ghrelin receptor in periodontal cells
    Nokhbehsaim, Marjan
    Memmert, Svenja
    Damanaki, Anna
    Nanayakkara, Shanika
    Zhou, Xiaoyan
    Jaeger, Andreas
    Deschner, James
    CLINICAL ORAL INVESTIGATIONS, 2019, 23 (01) : 113 - 122
  • [49] Association of Interleukin-1 Beta and Interleukin-1 Receptor Antagonist Gene Polymorphisms and Plasma Levels with Diabetic Nephropathy
    Liao, Xueling
    Xiao, Yanan
    Elbelt, Ulf
    Weylandt, Karsten H.
    Li, Kanghui
    Deng, Jie
    Zeng, Ning
    Xue, Chao
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [50] Regulation of interleukin-1β by the interleukin-1 receptor antagonist in the glutamate-injured spinal cord:: Endogenous neuroprotection
    Liu, Song
    Xu, Guo-Ying
    Johnson, Kathia M.
    Echetebu, Clement
    Ye, Zaiming
    Hulsebosch, Claire E.
    McAdoo, David J.
    BRAIN RESEARCH, 2008, 1231 : 63 - 74